Other clinicopathological or molecular markers have recently been considered promising predictors of prognosis in colorectal cancer, such as serum CEA, serum CA-199, serum cytokeratin 19 fragment, and degree of tumor differentiation (25, 26). The gene discussed is KRT19; the disease is neoplasm.